Seth E. Karol
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Seth E. Karol as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07008027 · Real World Asparaginase Therapy ToxicitySt. Jude Children's Research Hospital · not yet recruiting · Drug Toxicity · principal investigator
- Ph2NCT06390319 · Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)St. Jude Children's Research Hospital · recruiting · T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, Mixed Phenotype Acute Leukemia · principal investigator
- Ph4NCT06289673 · Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/LymphomaSt. Jude Children's Research Hospital · recruiting · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia · principal investigator
- Ph1/Ph2NCT05192889 · Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and NavitoclaxSt. Jude Children's Research Hospital · active not recruiting · Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia · principal investigator
- Ph2NCT04401267 · Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/LymphomaSt. Jude Children's Research Hospital · completed · Hypertension, Osteonecrosis, Osteonecrosis Due to Drug · principal investigator
- Ph1/Ph2NCT04195347 · Study of CM4620 to Reduce the Severity of Pancreatitis Due to AsparaginaseSt. Jude Children's Research Hospital · recruiting · Acute Pancreatitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic LeukemiaK08CA250418 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2020 to 2024 · $224,070 awarded in 2024Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:27 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.Lancet Oncol · 2020143 citationsRCR 6.5
- 59 citationsRCR 2.3
- Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.Blood Adv · 202259 citationsRCR 3.6
- 29 citationsRCR 0.8
- 18 citationsRCR 4.0
- Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.Pediatr Blood Cancer · 202515 citationsRCR 3.4
- Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia.Blood Adv · 202313 citationsRCR 1.3
- Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.JAMA Netw Open · 202413 citationsRCR 1.8
- Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia.Leukemia · 202311 citationsRCR 0.9
- 11 citationsRCR 1.7